Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gent

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Thorax|May 1, 1981
Synergism between ipratropium and theophylline in asthmaH Kreisman, H Frank, N Wolkove, et al.
Annals of Internal Medicine|April 15, 1989
Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelinesP Tugwell, K Bennett, M Bell, et al.
The New England Journal of Medicine|December 4, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts)E Genton, M Gent, J Hirsh, et al.
Archives of Physical Medicine and Rehabilitation|June 1, 1975
Problem oriented medical records: their impact on staff communication, attitudes and decision makingS M Dinsdale, M Gent, G Kline, et al.
Circulation|August 1, 1996
Dual-chamber versus ventricular pacing. Critical appraisal of current dataS J Connolly, C Kerr, M Gent, et al.
Progress in Hematology|January 1, 1975
Critical evaluation of platelet-inhibiting drugs in thrombotic diseaseL A Harker, J Hirsh, M Gent, et al.
Brain Research|January 24, 2006
ROR alpha in genetic control of cerebellum development: 50 staggering yearsDavid A Gold, Peter M Gent, Bruce A Hamilton
The New England Journal of Medicine|December 11, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts)E Genton, M Gent, J Hirsh, et al.
The New England Journal of Medicine|December 18, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts)E Genton, M Gent, J Hirsh, et al.
Thrombosis Research|January 1, 1981
Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparinC J Carter, J G Kelton, J Hirsh, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Thorax|May 1, 1981
Synergism between ipratropium and theophylline in asthmaH Kreisman, H Frank, N Wolkove, et al.
Annals of Internal Medicine|April 15, 1989
Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelinesP Tugwell, K Bennett, M Bell, et al.
The New England Journal of Medicine|December 4, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts)E Genton, M Gent, J Hirsh, et al.
Archives of Physical Medicine and Rehabilitation|June 1, 1975
Problem oriented medical records: their impact on staff communication, attitudes and decision makingS M Dinsdale, M Gent, G Kline, et al.
Circulation|August 1, 1996
Dual-chamber versus ventricular pacing. Critical appraisal of current dataS J Connolly, C Kerr, M Gent, et al.
Progress in Hematology|January 1, 1975
Critical evaluation of platelet-inhibiting drugs in thrombotic diseaseL A Harker, J Hirsh, M Gent, et al.
Brain Research|January 24, 2006
ROR alpha in genetic control of cerebellum development: 50 staggering yearsDavid A Gold, Peter M Gent, Bruce A Hamilton
The New England Journal of Medicine|December 11, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts)E Genton, M Gent, J Hirsh, et al.
The New England Journal of Medicine|December 18, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts)E Genton, M Gent, J Hirsh, et al.
Thrombosis Research|January 1, 1981
Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparinC J Carter, J G Kelton, J Hirsh, et al.
Pageof 25